Invention Grant
US07670788B2 Determining and reducing immunoresistance to a Botulinum toxin therapy using Botulinum toxin B peptides
有权
使用肉毒杆菌毒素B肽确定和降低对肉毒杆菌毒素治疗的免疫耐受性
- Patent Title: Determining and reducing immunoresistance to a Botulinum toxin therapy using Botulinum toxin B peptides
- Patent Title (中): 使用肉毒杆菌毒素B肽确定和降低对肉毒杆菌毒素治疗的免疫耐受性
-
Application No.: US12061952Application Date: 2008-04-03
-
Publication No.: US07670788B2Publication Date: 2010-03-02
- Inventor: M. Zouhair Atassi
- Applicant: M. Zouhair Atassi
- Applicant Address: US CA Irvine US TX Houston
- Assignee: Allergan, Inc.,Baylor College of Medicine
- Current Assignee: Allergan, Inc.,Baylor College of Medicine
- Current Assignee Address: US CA Irvine US TX Houston
- Agency: Allergan, Inc.
- Agent Dean G. Stathakis; Joel B. German
- Main IPC: G01N33/53
- IPC: G01N33/53
Abstract:
The present invention provides BoNT/B peptides, BoNT/B peptide compositions, tolerogizing compositions, immune response inducing compositions, as well as methods of determining immunoresistance to botulinum toxin therapy in an individual, methods of treating immunoresistance to botulinum toxin therapy in an individual, methods of reducing anti-botulinum toxin antibodies in an individual and methods of inducing a BoNT/B immune response an individual.
Public/Granted literature
- US20080213255A1 DETERMINING AND REDUCING IMMUNORESISTANCE TO A BOTULINUM TOXIN THERAPY USING BOTULINUM TOXIN B PEPTIDES Public/Granted day:2008-09-04
Information query
IPC分类:
